UWM Holdings Corporation
UWMC is a leveraged mortgage-cycle call trading at 0.16x sales and 78.9% below its 52-week high, with survival risk reduced by the Oaktree recap but upside still dependent on rates, margins, and management regaining credibility after volatile execution.
The market is pricing UWMC as a broken mortgage lender with damaged credibility, and that is directionally fair, but it may now be too harsh on the equity after the balance-sheet reset. At $1.51, the stock trades at 0.16x FY2025 sales with a market cap of $3.3B, after falling 78.9% from its $7.14 52-week high and 48.29% in the last three months. Those are rescue-valuation conditions. The key change is that this no longer looks like a pure solvency debate. The Oaktree transaction adds $2B+ of capital, lifts total equity to roughly $3B, and cuts nonfunding debt-to-equity to 1.2x from the roughly 5.6x level management cited at quarter-end after the Q2 hedge shock.
The long case depends on three things. First, the core origination engine must still be economically relevant. The evidence is mixed but not absent: UWMC still did roughly $40B of business in Q2 2026, and management claims current run-capacity of $250B-$300B. Second, the earnings trough must prove cyclical rather than structural. In 2024 Q3, the platform showed what normalized operating leverage can look like, with $39.5B production and 118 bps gain margin. Third, the company must keep more of the recovery for common holders than the market now assumes. That is harder after taking on preferred capital costing $100M-$165M annually with a 10% coupon plus warrants.
What keeps conviction low is that management has not earned a clean rebound multiple. FY2025 was weak across the board, revenue -25.8%, EPS -89.2%, operating margin down to 9.2%, and the latest quarter was ugly with -0.23 EPS versus 0.07308 expected. The latest call also gave little explicit operating guidance, even after the recap, while Q2 EBITDA margin collapsed to 5.5% from 36.9% in Q1. That makes it hard to underwrite near-term earnings power with precision.
Still, the stock does not need perfection. It needs proof that the company is stabilized, that servicing-transition costs and hedge noise are temporary, and that a better rate backdrop can convert capacity into earnings. If those pieces show up over the next several quarters, the common can work from this level. If they do not, the preferred stack and dilution terms leave little room for error.
Rates fall, volume moves toward management's $60B-$80B quarterly upside case, and the market starts valuing UWMC on normalized earnings instead of rescue financing optics.
Balance-sheet repair holds, servicing-transition costs ease, and origination and margins normalize enough to support the engine's $2.58 low-confidence target.
Margins stay near Q2's depressed level, litigation and recap overhang persist, and preferred costs of $100M-$165M eat most of the recovery for common holders.
Quant call aligns with analyst consensus (Strong Buy: 4 buy / 1 hold / 0 sell).
We don't buy stocks where they are, we buy them where they're going.
Forward earnings power is far better than the trailing FY2025 EPS of $0.13 suggests if mortgage rates ease, but the path is noisy and the market no longer gives management the benefit of the doubt after multiple misses and a Q2 2026 EPS loss of -0.23. The moat today is still the broker-first origination platform and scale, but over 3-5 years it looks more like a cost and speed advantage than a pricing moat, and AI mostly helps incumbents that automate underwriting, broker workflow, and servicing rather than creating new demand. Regulation and housing affordability still cap TAM near term, but if AI and internal tech actually reduce fulfillment cost while the company retains its $250B-$300B run-capacity, normalized earnings could be materially higher than current sentiment implies. That is enough for a BUY, but only with Low conviction because the common now sits behind expensive preferred capital and needs cleaner execution to unlock that operating leverage.
- Post-Oaktree equity rises to roughly $3B and nonfunding debt-to-equity falls to 1.2x, versus management's comment that quarter-end leverage had spiked to about 5.6x.
- Valuation is distressed at 0.16x P/S versus 3.0x peer average, while the quant engine's base target is $2.58, or 71.1% above the current $1.51.
- Operating power is highly rate-sensitive: management says a rate-drop scenario could drive $60B-$80B quarterly origination volume, against roughly $40B of business in the recent tough quarter.
- The balance sheet is meaningfully less fragile after the $2B+ Oaktree transaction, with total equity moving from about $1B to roughly $3B and annualized interest expense savings of about $100M.
- The platform still processed about $40B of business in Q2 2026 despite a weak market, supporting management's claim that the origination machine remains functional even before a housing recovery.
- The stock already discounts a lot: shares sit -78.9% below the $7.14 52-week high and -61.2% below the $3.89 200-day average, so even a partial normalization in earnings power can move the equity sharply.
- Historical operating capacity is real. In 2024 Q3, production reached $39.5B, above guidance, and gain margin hit 118 bps, above the guided 85-110 bps range, showing the platform can monetize volume when the market window opens.
- FY2025 fundamentals deteriorated hard, with revenue down 25.8% to $3.2B, EPS down 89.2% to $0.13, operating margin down to 9.2% from 17.6%, and net margin just 1.8%.
- Recent execution has been erratic: the last eight reported quarters include five misses, capped by the 2026-08-06 EPS of -0.23 versus 0.07308 expected, a -414.7% miss.
- The capital raise solved one problem but created another. Preferred capital costs $100M-$165M annually and carries a 10% coupon plus warrants, which raises the bar for common-equity recovery.
- Short interest is extremely high at 59.59% of shares outstanding in the headline data, with deep-dive data showing 78.9M shares short, 4.1 days-to-cover, and a negative near-term options gamma regime, all signs the market is positioned for more volatility and potential downside.
| Metric | Value | Context |
|---|---|---|
| Current price | $1.51 | Reference price for upside and scenario analysis |
| Quant price target | $2.58 | 71.1% above current, Low confidence, basis: sales_quality_blend |
| Method blend | P/S Multiple $3.55, Quality-adjusted $1.43 | Wide spread shows sensitivity to quality and balance-sheet concerns |
| FY2025 revenue | $3.2B | -25.8% YoY |
| FY2025 EPS | $0.13 | -89.2% YoY |
| FY2025 operating margin | 9.2% | Down from 17.6% in prior FY |
| Net margin | 1.8% | Thin profitability for a leveraged lender |
| Valuation | P/S 0.16, P/B 3.84, P/E N/A | Peer averages: P/S 3.0, P/E 14.2 |
| Balance sheet leverage | Debt/Equity 109.53, Debt/EBITDA 17.61, Total debt $14.6B | Heavy leverage, partially addressed by recap |
| Post-transaction balance sheet | Equity roughly $3B, nonfunding debt-to-equity 1.2x | Management's latest call after Oaktree deal |
| Recent quarter profitability | Q2 2026 EBITDA $0.05B on $0.89B revenue, margin 5.5% | Down 3,140 bps versus Q1's 36.9% |
| Price action | 1W -17.93%, 1M -24.50%, 3M -48.29% | Now -78.9% vs 52-week high and -61.2% below 200-day average |
The biggest risk is that operating earnings stay too weak to cover the higher capital burden, with Q2 2026 EBITDA margin collapsing to 5.5% from 36.9% in Q1 while preferred payout expense runs $100M-$165M annually.
The next catalyst is Q3 earnings on November 5, 2026, specifically whether margins recover from Q2's 5.5% EBITDA margin and whether management finally gives firmer operating guidance after the recap.
Ownership is unusual and crowded. The top three institutions are listed at 115.0%, insider ownership is 12.0%, and short interest is elevated at 59.59% in the headline data, with deep-dive figures showing 78.9M shares short and 4.1 days-to-cover versus a 132M float. Near-term options positioning is in a negative gamma regime, which can amplify moves both ways, so the setup supports squeeze risk on good news but also signals that investors remain positioned for instability rather than recovery.
Recent quarter handled roughly $40B of business; management says current run-capacity is $250B-$300B annually and could reach $60B-$80B in a quarter if rates fall.
MSR strategy remains opportunistic, retain/build or sell when pricing is attractive; rate moves can create mark-to-market volatility and management openly accepts MSR write-down risk if origination volumes surge.
Business is tied to U.S. mortgage demand, broker channel share, housing turnover, and rate sensitivity rather than geographic diversification.
UWM emphasized a fortified balance sheet after the Oaktree deal, but gave little explicit operating guidance.
Execution has slipped versus what management suggested in the 2024 Q3 call. Back then, UWMC delivered $39.5B production above guidance, 118 bps gain margin above the guided 85-110 bps, and $32M net income, while management said, "I think that will be 2025, and I think you'll see the results in our volume growing and our margins growing next year." What followed was not that. FY2025 revenue fell 25.8% to $3.2B, EPS fell 89.2% to $0.13, and operating margin dropped to 9.2% from 17.6%. The earnings track record since then is choppy, with five misses in the last eight quarters, including the recent -414.7% miss. To management's credit, they did act decisively on the balance sheet in 2026, raising $2B+ with Oaktree and reducing nonfunding leverage to 1.2x, but operating guidance on the latest call was thin. Credibility is mixed: strong operator in market-share defense and financing actions, weak on near-term earnings predictability.
Before I get into that, obviously, from a second quarter perspective, operating income, over $180 million EBITDA -- adjusted EBITDA along with about $40 billion of business.
The next 4 or 5 years are going to be significantly better.
The key thing is the total equity increases from $1 billion to roughly $3 billion and growing, right?
And the nonfunding debt-to-equity declines from -- it was -- with the end of the quarter, it jumped up to a really high number because of the hedging and the negative we had in the second quarter to over 5x or I think it was 5.6x, but now we're down to 1.2x.
I hope rates drop sharply, and we have to deal with the MSR write-down. That will be a fine problem to have because the origination machine will kick in. We'll do $60 billion, $70 billion, $80 billion in a quarter at big margins.
UWMC's edge is scale in wholesale mortgage origination, broker relationships, and the ability to flex volume without major incremental hiring, which management emphasized in both the 2024 and 2026 calls. The moat is real but not untouchable: it is strongest in speed, service, and unit cost, not in customer captivity, so durability depends on staying technologically ahead and preserving broker loyalty. Over time, AI should strengthen the lowest-cost, fastest-processing platforms, which helps UWMC if its internal tools actually reduce cycle times and per-loan cost faster than peers.
Capital allocation turned defensive. Dividends were suspended, buybacks were $0.0B, dividends were $0.0B, and capex was $0.0B in the deep-dive data as management prioritized balance-sheet repair over shareholder distributions. The Oaktree financing fortified liquidity and cuts annualized interest expense by about $100M, but the trade-off is expensive preferred capital at a 10% coupon plus warrants, so future common-share value creation requires a return to consistent earnings rather than financial engineering.
UWMC rates a BUY at Low conviction. The stock is washed out, the balance sheet is meaningfully safer after the recap, and the valuation already embeds a lot of pain. That creates upside if mortgage volumes recover and margins revert even partway toward prior-cycle levels. The catch is simple: management has to prove that Q2 was an anomaly, not the template. A shift to HOLD or SELL would require evidence that EBITDA margins stay near 5.5%, that preferred-cost drag overwhelms recovery, or that another quarter of major misses shows the platform's earnings power has structurally reset lower.
≣ Full research note tap to expand
Executive Summary
BUY, Low conviction. Rated BUY, Low conviction. The stock now reflects extreme skepticism after a -48.29% three-month collapse, a fresh Q2 EPS miss of -414.7%, and a heavily dilutive rescue-style capital raise, yet the recap lifts equity to roughly $3B and cuts nonfunding debt-to-equity to 1.2x, which materially lowers near-term balance-sheet risk. The debate is no longer solvency versus upside, it is whether the company can convert its $250B-$300B origination capacity into normalized earnings when rates and mortgage demand improve.
Investment Thesis
The market is pricing UWMC as a broken mortgage lender with damaged credibility, and that is directionally fair, but it may now be too harsh on the equity after the balance-sheet reset. At $1.51, the stock trades at 0.16x FY2025 sales with a market cap of $3.3B, after falling 78.9% from its $7.14 52-week high and 48.29% in the last three months. Those are rescue-valuation conditions. The key change is that this no longer looks like a pure solvency debate. The Oaktree transaction adds $2B+ of capital, lifts total equity to roughly $3B, and cuts nonfunding debt-to-equity to 1.2x from the roughly 5.6x level management cited at quarter-end after the Q2 hedge shock.
The long case depends on three things. First, the core origination engine must still be economically relevant. The evidence is mixed but not absent: UWMC still did roughly $40B of business in Q2 2026, and management claims current run-capacity of $250B-$300B. Second, the earnings trough must prove cyclical rather than structural. In 2024 Q3, the platform showed what normalized operating leverage can look like, with $39.5B production and 118 bps gain margin. Third, the company must keep more of the recovery for common holders than the market now assumes. That is harder after taking on preferred capital costing $100M-$165M annually with a 10% coupon plus warrants.
What keeps conviction low is that management has not earned a clean rebound multiple. FY2025 was weak across the board, revenue -25.8%, EPS -89.2%, operating margin down to 9.2%, and the latest quarter was ugly with -0.23 EPS versus 0.07308 expected. The latest call also gave little explicit operating guidance, even after the recap, while Q2 EBITDA margin collapsed to 5.5% from 36.9% in Q1. That makes it hard to underwrite near-term earnings power with precision.
Still, the stock does not need perfection. It needs proof that the company is stabilized, that servicing-transition costs and hedge noise are temporary, and that a better rate backdrop can convert capacity into earnings. If those pieces show up over the next several quarters, the common can work from this level. If they do not, the preferred stack and dilution terms leave little room for error.
Key Metrics
| Metric | Value | Context |
|---|---|---|
| Current price | $1.51 | Reference price for upside and scenario analysis |
| Quant price target | $2.58 | 71.1% above current, Low confidence, basis: sales_quality_blend |
| Method blend | P/S Multiple $3.55, Quality-adjusted $1.43 | Wide spread shows sensitivity to quality and balance-sheet concerns |
| FY2025 revenue | $3.2B | -25.8% YoY |
| FY2025 EPS | $0.13 | -89.2% YoY |
| FY2025 operating margin | 9.2% | Down from 17.6% in prior FY |
| Net margin | 1.8% | Thin profitability for a leveraged lender |
| Valuation | P/S 0.16, P/B 3.84, P/E N/A | Peer averages: P/S 3.0, P/E 14.2 |
| Balance sheet leverage | Debt/Equity 109.53, Debt/EBITDA 17.61, Total debt $14.6B | Heavy leverage, partially addressed by recap |
| Post-transaction balance sheet | Equity roughly $3B, nonfunding debt-to-equity 1.2x | Management's latest call after Oaktree deal |
| Recent quarter profitability | Q2 2026 EBITDA $0.05B on $0.89B revenue, margin 5.5% | Down 3,140 bps versus Q1's 36.9% |
| Price action | 1W -17.93%, 1M -24.50%, 3M -48.29% | Now -78.9% vs 52-week high and -61.2% below 200-day average |
Financial Strength
Financial strength is the central swing factor. On reported FY2025 numbers, this is a weak balance sheet, with $14.6B of debt, 109.53 debt-to-equity, 17.61 debt-to-EBITDA, a 1.00 current ratio, and no free cash flow. The Oaktree transaction improves that picture materially by raising equity to roughly $3B and reducing nonfunding leverage to 1.2x, which lowers immediate survival risk, but the economics for common holders are still strained because the fix came with expensive preferred capital and warrants. Margin trajectory is the bigger question now: if Q2's 5.5% EBITDA margin proves temporary, the recap buys time for a recovery; if it is closer to the new normal, the capital structure remains too heavy for the common to compound well.
Competitive Position
UWMC's edge is scale in wholesale mortgage origination, broker relationships, and the ability to flex volume without major incremental hiring, which management emphasized in both the 2024 and 2026 calls. The moat is real but not untouchable: it is strongest in speed, service, and unit cost, not in customer captivity, so durability depends on staying technologically ahead and preserving broker loyalty. Over time, AI should strengthen the lowest-cost, fastest-processing platforms, which helps UWMC if its internal tools actually reduce cycle times and per-loan cost faster than peers.
Management & Guidance
Management's latest guidance is more strategic than financial. The company gave tangible balance-sheet targets, roughly $3B of equity, 1.2x nonfunding debt-to-equity, and about $100M in annualized interest expense savings, but offered little explicit quarterly or full-year operating guidance after a volatile quarter. The upside case they did give is substantial, $60B-$80B of quarterly volume if rates fall, but that is scenario language rather than a forecast. Given the track record of five misses in the last eight quarters and the recent -414.7% EPS miss, that guidance should be treated as directional, not underwritten at face value.
Segment Analysis
- Mortgage origination (Primary earnings driver, exact FY2025 split not disclosed here): Recent quarter handled roughly $40B of business; management says current run-capacity is $250B-$300B annually and could reach $60B-$80B in a quarter if rates fall.
- Mortgage servicing rights and servicing-related income (Meaningful but volatile, exact FY2025 split not disclosed here): MSR strategy remains opportunistic, retain/build or sell when pricing is attractive; rate moves can create mark-to-market volatility and management openly accepts MSR write-down risk if origination volumes surge.
- United States (Effectively ~100%): Business is tied to U.S. mortgage demand, broker channel share, housing turnover, and rate sensitivity rather than geographic diversification.
Capital Allocation
Capital allocation turned defensive. Dividends were suspended, buybacks were $0.0B, dividends were $0.0B, and capex was $0.0B in the deep-dive data as management prioritized balance-sheet repair over shareholder distributions. The Oaktree financing fortified liquidity and cuts annualized interest expense by about $100M, but the trade-off is expensive preferred capital at a 10% coupon plus warrants, so future common-share value creation requires a return to consistent earnings rather than financial engineering.
Management Execution & Track Record
Execution has slipped versus what management suggested in the 2024 Q3 call. Back then, UWMC delivered $39.5B production above guidance, 118 bps gain margin above the guided 85-110 bps, and $32M net income, while management said, "I think that will be 2025, and I think you'll see the results in our volume growing and our margins growing next year." What followed was not that. FY2025 revenue fell 25.8% to $3.2B, EPS fell 89.2% to $0.13, and operating margin dropped to 9.2% from 17.6%. The earnings track record since then is choppy, with five misses in the last eight quarters, including the recent -414.7% miss. To management's credit, they did act decisively on the balance sheet in 2026, raising $2B+ with Oaktree and reducing nonfunding leverage to 1.2x, but operating guidance on the latest call was thin. Credibility is mixed: strong operator in market-share defense and financing actions, weak on near-term earnings predictability.
Positioning & Flows
Ownership is unusual and crowded. The top three institutions are listed at 115.0%, insider ownership is 12.0%, and short interest is elevated at 59.59% in the headline data, with deep-dive figures showing 78.9M shares short and 4.1 days-to-cover versus a 132M float. Near-term options positioning is in a negative gamma regime, which can amplify moves both ways, so the setup supports squeeze risk on good news but also signals that investors remain positioned for instability rather than recovery.
Bull Case
- The balance sheet is meaningfully less fragile after the $2B+ Oaktree transaction, with total equity moving from about $1B to roughly $3B and annualized interest expense savings of about $100M.
- The platform still processed about $40B of business in Q2 2026 despite a weak market, supporting management's claim that the origination machine remains functional even before a housing recovery.
- The stock already discounts a lot: shares sit -78.9% below the $7.14 52-week high and -61.2% below the $3.89 200-day average, so even a partial normalization in earnings power can move the equity sharply.
- Historical operating capacity is real. In 2024 Q3, production reached $39.5B, above guidance, and gain margin hit 118 bps, above the guided 85-110 bps range, showing the platform can monetize volume when the market window opens.
Bear Case
- FY2025 fundamentals deteriorated hard, with revenue down 25.8% to $3.2B, EPS down 89.2% to $0.13, operating margin down to 9.2% from 17.6%, and net margin just 1.8%.
- Recent execution has been erratic: the last eight reported quarters include five misses, capped by the 2026-08-06 EPS of -0.23 versus 0.07308 expected, a -414.7% miss.
- The capital raise solved one problem but created another. Preferred capital costs $100M-$165M annually and carries a 10% coupon plus warrants, which raises the bar for common-equity recovery.
- Short interest is extremely high at 59.59% of shares outstanding in the headline data, with deep-dive data showing 78.9M shares short, 4.1 days-to-cover, and a negative near-term options gamma regime, all signs the market is positioned for more volatility and potential downside.
Valuation & Price Target
Engine price target $2.58 (+71.1% vs current), Low confidence.
- P/S Multiple: $3.55 (24% weight)
- Quality-adjusted: $1.43 (20% weight)
This view aligns with the quant baseline BUY, but the conviction stays Low for the same reason the engine flags low confidence. The quant target of $2.58 is supported by extreme valuation compression at 0.16x sales and a post-recap balance sheet that looks far safer with roughly $3B of equity, yet the peer-based read is noisy because the comp set has wide P/E dispersion of 8.2x and UWMC's own P/E is N/A after earnings deterioration. The sell-side consensus is also bullish, but that is low-signal context here. The rating remains BUY because survival odds improved materially and the stock is priced for deep distress, not because recent execution deserves trust.
Risk Assessment
Risk score 57/100 (Moderate). The biggest risk is that operating earnings stay too weak to cover the higher capital burden, with Q2 2026 EBITDA margin collapsing to 5.5% from 36.9% in Q1 while preferred payout expense runs $100M-$165M annually.
The Bottom Line
UWMC rates a BUY at Low conviction. The stock is washed out, the balance sheet is meaningfully safer after the recap, and the valuation already embeds a lot of pain. That creates upside if mortgage volumes recover and margins revert even partway toward prior-cycle levels. The catch is simple: management has to prove that Q2 was an anomaly, not the template. A shift to HOLD or SELL would require evidence that EBITDA margins stay near 5.5%, that preferred-cost drag overwhelms recovery, or that another quarter of major misses shows the platform's earnings power has structurally reset lower.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr